WHPM, Inc.
Daisy Wan has held various roles in different companies throughout their career. Daisy began as a Medical Receptionist and Shadowing Intern at LUNING CHEN M.D. MEDICAL CORPORATION in 2017. Daisy then worked as a Research Assistant at UCLA Health from 2017 to 2020. In 2022, they served as a Medical Assistant at WUHUA JING M.D., PH.D., P.C. Additionally, in 2023, they became the Chief Executive Officer at Hemosure®, American Drug Screen Corporation, and WHPM, Inc. Daisy also volunteered as a Research Assistant at NYU Langone Health starting in 2023.
Daisy Wan is currently an undergraduate student at New York University, where they are pursuing a B.A. in Psychology with a Double Minor in Chemistry and Genetics on the Premed Track. Prior to attending NYU, they obtained their High School Diploma from Harvard-Westlake School.
This person is not in any teams
This person is not in any offices
WHPM, Inc.
W.H.P.M., Inc., established in 1993, is a privately held corporation headquartered at Irwindale, California, only 15 minutes away from downtown Los Angeles. The Company is a pioneer in the research and development of one-step rapid membrane tests. It has been designated a registered GMP facility for in vitro diagnostic medical devices by the FDA.